Carney complex
|
WikiDoc Resources for Carney complex |
|
Articles |
|---|
|
Most recent articles on Carney complex Most cited articles on Carney complex |
|
Media |
|
Powerpoint slides on Carney complex |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Carney complex at Clinical Trials.gov Trial results on Carney complex Clinical Trials on Carney complex at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Carney complex NICE Guidance on Carney complex
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Carney complex Discussion groups on Carney complex Patient Handouts on Carney complex Directions to Hospitals Treating Carney complex Risk calculators and risk factors for Carney complex
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Carney complex |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
| Cardiology Network |
 Discuss Carney complex further in the WikiDoc Cardiology Network |
| Adult Congenital |
|---|
| Biomarkers |
| Cardiac Rehabilitation |
| Congestive Heart Failure |
| CT Angiography |
| Echocardiography |
| Electrophysiology |
| Cardiology General |
| Genetics |
| Health Economics |
| Hypertension |
| Interventional Cardiology |
| MRI |
| Nuclear Cardiology |
| Peripheral Arterial Disease |
| Prevention |
| Public Policy |
| Pulmonary Embolism |
| Stable Angina |
| Valvular Heart Disease |
| Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Carney complex is an autosomal dominant condition comprising myxomas of the heart and skin, hyperpigmentation of the skin (lentiginosis), and endocrine overactivity (Carney et al, 1985; McCarthy et al, 1986). It must be differentiated from Carney syndrome (also known as Carney triad). Approximately 7% of all cardiac myxomas are associated with Carney complex(Reynen 1995).
Pathophysiology
The majority of cases of Carney complex are caused by mutations in the PRKAR1-α gene on chromosome 17q24, which has been suggested to function as a tumor-suppressor gene.
Clinical Features
The spotty skin pigmentation and lentigines occur most commonly on the face, especially on the lips, eyelids, conjunctiva, and oral mucosa (McCarthy et al, 1986). Cardiac myxomas may lead to embolic strokes and heart failure (Reynen, 1995) and may present with fever, joint pain, shortness of breath, diastolic rumble, and tumor plop. Myxomas may also occur outside the heart, usually in the skin and breast. Endocrine tumors may manifest as disorders such as Cushing syndrome.
Treatment
Cardiac myxomas can be difficult to remove surgically because of recurrence within the heart, often far away from the site of the initial tumor. (McCarthy et al, 1986; Reynen, 1995).
Related Disorders
LAMB (lentigines, atrial myxoma, mucocutaneous myxoma, blue nevi) and NAME (nevi, atrial myxoma, myxoid neurofibromata, ephelides) syndromes are considered variants of Carney complex.
References
- Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL (1985). "The complex of myxomas, spotty pigmentation, and endocrine overactivity". Medicine (Baltimore). 64 (4): 270–83. PMID 4010501.
- McCarthy PM, Piehler JM, Schaff HV, Pluth JR, Orszulak TA, Vidaillet HJ Jr, Carney JA (1986). "The significance of multiple, recurrent, and "complex" cardiac myxomas". J Thorac Cardiovasc Surg. 91 (3): 389–96. PMID 3951243.
- Reynen K (1995). "Cardiac myxomas". N Engl J Med. 333 (24): 1610–7. PMID 7477198.
- Stratakis CA, Kirschner LS, Carney JA (2001). "Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation". J Clin Endocrinol Metab. 86 (9): 4041–6. PMID 11549623.
External links